The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher’s disease
- 1 April 2001
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 138 (4) , 539-547
- https://doi.org/10.1067/mpd.2001.112171
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Visual confrontation naming following left anterior temporal lobectomy: A comparison of surgical approaches.Neuropsychology, 1999
- Empirical methods for assessing meaningful neuropsychological change following epilepsy surgeryJournal of the International Neuropsychological Society, 1996
- Acceleration of retarded growth in children with Gaucher disease after treatment with algluceraseThe Journal of Pediatrics, 1996
- Enzyme Infusion Therapy of the Norrbottnian (Type 3) Gaucher DiseaseNeuropediatrics, 1995
- Enzyme replacement treatment in type 1 and type 3 Gaucher's diseaseThe Lancet, 1994
- HCG contamination of alglucerase: Clinical implications in low‐dose regimenAmerican Journal of Hematology, 1994
- Individual change after epilepsy surgery: Practice effects and base-rate information.Neuropsychology, 1993
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Gaucher's disease and portal hypertensionBritish Journal of Surgery, 1970
- Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease.Journal of Clinical Investigation, 1966